553Biologics
53Biologics is a Spanish contract development and manufacturing organization (CDMO) based in Valladolid specializing in biologics production, from plasmid DNA and mRNA components to recombinant proteins, offering cell line development, analytical and process development, and GMP manufacturing from preclinical through commercial stages. Founded in 2017 as a biopharmaceutical subsidiary of the BDi Biotechnology Group, it has raised venture funding from Inveready and GAEA Inversión and in 2026 took on a majority-stake investment from European private equity firm Ren Life Sciences to expand its GMP biomanufacturing capacity.
SectorsBiotechnology, CDMO, Biologics Manufacturing, Life Sciences
Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO
Founders
P
Pablo Gutiérrez Gómez
CEO & Founder
Global models 5
NNational Resilience
United States · resilience.com ↗
A large-scale biomanufacturing CDMO offering end-to-end drug substance and biologics production infrastructure, directly comparable to 53Biologics' contract manufacturing model.
$2.0BComparable
EElevateBio
United States · elevate.bio ↗
Combines a biotech platform with its own BaseCamp CDMO facilities for cell and gene therapy and biologics manufacturing, similar to 53Biologics' development-plus-manufacturing offering.
$1.3BComparable
CCellares
United States · cellares.com ↗
An integrated development and manufacturing organization (IDMO) automating biologics/cell therapy production at scale, matching 53Biologics' CDMO service model.
$612MComparable
AAldevron
United States · www.aldevron.com ↗
The world's largest cGMP plasmid DNA manufacturer, essentially the same core plasmid DNA CDMO business as 53Biologics before being acquired by Danaher for $9.6B.
$250M (VC/PE, pre-acquisition)Comparable
AAbsci
United States · www.absci.com ↗
A biologics company combining recombinant protein development with manufacturing services, paralleling 53Biologics' recombinant protein and process development work.
$225MComparable
In the same niche 8 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 3
Open as list →
Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-25 | No stage disclosed | — |
Ren Life Sciences
+1 more
|
| 2021-09-10 | Series A (estimated) | €7M |
Lead not disclosed
+2 more
|
News 5
Open as list →| Published | Article |
|---|---|
| 2026-03-25 |
53Biologics drives its expansion in GMP biomanufacturing with an investment led by Ren Life Sciences and supported by Inveready ↗
Biotech Spain
2026-03-25 |
| 2024-10-11 |
53Biologics, la vallisoletana que ayuda a las pequeñas compañías a desarrollar terapias innovadoras ↗
El Economista
2024-10-11 |
| 2024-09-26 |
53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum ↗
AseBio
2024-09-26 |
| 2023-05-10 |
53Biologics Unveils New GMP Production Line for Biologics ↗
Contract Pharma
2023-05-10 |
| 2023-03-17 |
53Biologics Expands its State-of-the-art Facilities ↗
Contract Pharma
2023-03-17 |